OurCrowd portfolio company ReWalk Robotics was featured in Globes, the leading Israeli financial daily. FDA approved ReWalk has developed an exoskeleton device that enables paraplegics with an independent, natural walking experience that provides them numerous social, psychological, and physical benefits.

ReWalk Robotics has set terms for its Nasdaq IPO. The Yokneam-based company recently changed its name from Argo Medical Technologies to its flagship product, which is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.

The IPO is set to take place in the second week of September.


ReWalk raised $1,320,000 from OurCrowd investors in June 2013.

Read more on Globes here.